16 May 2025 - New test provides less invasive option, reduces reliance on PET scans and increases diagnosis accessibility. ...
16 May 2025 - PharmaTher today announced the US FDA has extended the approval goal date for the review of ...
15 May 2025 - Product will be available for appropriate patients in the second half of 2025 ...
15 May 2025 - Independent appraisal committee voted that current evidence is adequate to demonstrate a net health benefit of ...
14 May 2025 - Kaerus Bioscience today announces that its lead candidate KER-0193 has been granted both orphan drug designation and ...
15 May 2025 - BrainChild Bio advancing BCB-276 towards BLA submission with a single pivotal Phase 2 trial planned to ...
15 May 2025 - Today, the FDA approved retifanlimab-dlwr (Zynyz, Incyte) with carboplatin and paclitaxel for the first-line treatment of ...
14 May 2025 - The US FDA has acknowledged receipt of Xspray Pharma's re-submitted new drug application) for Dasynoc. ...
14 May 2025 - Troriluzole would be the first and only FDA approved treatment for spinocerebellar ataxia, if approved. ...
14 May 2025 - FDA grants priority review of application, with PDUFA target action date of 12 September 2025. ...
14 May 2025 - Today, the FDA granted accelerated approval to telisotuzumab vedotin-tllv (Emrelis, AbbVie), a c-Met-directed antibody and microtubule ...
14 May 2025 - Today, the FDA approved belzutifan (Welireg, Merck) for adult and paediatric patients 12 years and older ...
7 May 2025 - A therapy under development at the University of Wisconsin School of Medicine and Public Health to ...
13 May 2025 - FDA assigns PDUFA target action date of 9 November 2025. ...
11 May 2025 - President Trump said Sunday he will sign an executive order Monday to cap prescription drug and ...